Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct 4;288(40):28925-35.
doi: 10.1074/jbc.M113.466466. Epub 2013 Aug 19.

Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy

Affiliations

Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy

Emily M Schulz et al. J Biol Chem. .

Abstract

Studies indicate that tropomyosin (Tm) phosphorylation status varies in different mouse models of cardiac disease. Investigation of basal and acute cardiac function utilizing a mouse model expressing an α-Tm protein that cannot be phosphorylated (S283A) shows a compensated hypertrophic phenotype with significant increases in SERCA2a expression and phosphorylation of phospholamban Ser-16 (Schulz, E. M., Correll, R. N., Sheikh, H. N., Lofrano-Alves, M. S., Engel, P. L., Newman, G., Schultz Jel, J., Molkentin, J. D., Wolska, B. M., Solaro, R. J., and Wieczorek, D. F. (2012) J. Biol. Chem. 287, 44478-44489). With these results, we hypothesized that decreasing α-Tm phosphorylation may be beneficial in the context of a chronic, intrinsic stressor. To test this hypothesis, we utilized the familial hypertrophic cardiomyopathy (FHC) α-Tm E180G model (Prabhakar, R., Boivin, G. P., Grupp, I. L., Hoit, B., Arteaga, G., Solaro, R. J., and Wieczorek, D. F. (2001) J. Mol. Cell. Cardiol. 33, 1815-1828). These FHC hearts are characterized by increased heart:body weight ratios, fibrosis, increased myofilament Ca(2+) sensitivity, and contractile defects. The FHC mice die by 6-8 months of age. We generated mice expressing both the E180G and S283A mutations and found that the hypertrophic phenotype was rescued in the α-Tm E180G/S283A double mutant transgenic animals; these mice exhibited no signs of cardiac hypertrophy and displayed improved cardiac function. These double mutant transgenic hearts showed increased phosphorylation of phospholamban Ser-16 and Thr-17 compared with the α-Tm E180G mice. This is the first study to demonstrate that decreasing phosphorylation of tropomyosin can rescue a hypertrophic cardiomyopathic phenotype.

Keywords: Calcium; Cardiac Hypertrophy; Muscle; Phosphorylation; Transgenic Mice; Tropomyosin.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
A, α-Tm E180G/S283A DMTG construct. The α-MHC promoter drives cardiac-specific expression of the striated muscle α-Tm with encoded substitutions at amino acids (aa) 180 (E180G) and 283 (S283A) on the same molecule. B, myofibrillar preparations resolved by SDS-PAGE and stained with Coomassie Blue. Note the small shift in migration between the α-Tm E180G and DMTG Tm samples. Arrows indicate DMTG endogenous and TG protein. C, quantification of endogenous Tm protein remaining in NTG, α-Tm E180G, α-Tm S283A, and DMTG samples. Error bars represent S.E.
FIGURE 2.
FIGURE 2.
A, immunoblot of phosphorylation status of α-Tm E180G hearts at 3 months of age. B, immunoblot of phosphorylation status of α-Tm S283A hearts at 3 months of age. C, immunoblot of phosphorylation status of DMTG hearts at 3 months of age. D, quantification of α-Tm phosphorylation in hearts from 3-month-old NTG, α-Tm E180G, α-Tm S283A, and DMTG mice. *, versus NTG, p < 0.05. E, two-dimensional SDS-PAGE of Tm from α-Tm E180G TG myofibers. Error bars represent S.E. pTm, phosphorylated Tm; α-Tm-p, phosphorylated α-Tm.
FIGURE 3.
FIGURE 3.
A, histological studies of NTG, α-Tm E180G, and DMTG hearts at 3 months of age stained with H&E, Masson's trichrome, and wheat germ agglutinin (WGA). Images were taken at 40×, and scale bars indicate 50 μm. B, cardiomyocyte cross-sectional area measurements (n = 6). *, versus NTG, p < 0.05; #, versus α-Tm E180G, p < 0.05. C, heart weight to body weight (HW:BW) ratios of 3-month-old mice (n = 6). Error bars represent S.E.
FIGURE 4.
FIGURE 4.
A, Ca2+-tension relations in skinned fiber bundles from NTG, α-Tm E180G, and DMTG hearts. B, normalized force relations in skinned fiber bundles from NTG, α-Tm E180G, and DMTG hearts. Error bars represent S.E. mN, millinewtons.
FIGURE 5.
FIGURE 5.
A–C, quantitative RT-PCR analysis of expression of the cardiomyopathy marker genes in 3-month-old NTG, α-Tm E180G, α-Tm S283A, and DMTG hearts. For NTG, n = 12; for E180G, n = 8; for S283A, n = 8; and for DMTG, n = 10. *, versus NTG, p < 0.05; #, versus α-Tm E180G, p < 0.05; @, versus α-Tm S283A, p < 0.05. Error bars represent S.E.
FIGURE 6.
FIGURE 6.
A, Western blots of sarcoplasmic Ca2+ flux proteins in NTG, α-Tm E180G, α-Tm S283A, and DMTG hearts. B, quantification of phosphorylation levels of PLN Ser-16 and PLN Thr-17. C, quantification of expression of PLN and SERCA2a. D, Western blots of TnI and phosphorylated TnI (pTnI) from NTG, α-Tm E180G, α-Tm S283A, and DMTG hearts. E, quantification of data from D. *, versus NTG, p < 0.05; #, versus α-Tm E180G, p < 0.05; @, versus α-Tm S283A, p < 0.05; n = 8. Error bars represent S.E.

Similar articles

Cited by

References

    1. Muthuchamy M., Pajak L., Howles P., Doetschman T., Wieczorek D. F. (1993) Developmental analysis of tropomyosin gene expression in embryonic stem cells and mouse embryos. Mol. Cell. Biol. 13, 3311–3323 - PMC - PubMed
    1. Mak A., Smillie L. B., Bárány M. (1978) Specific phosphorylation at serine-283 of α tropomyosin from frog skeletal and rabbit skeletal and cardiac muscle. Proc. Natl. Acad. Sci. U.S.A. 75, 3588–3592 - PMC - PubMed
    1. Montgomery K., Mak A. S. (1984) In vitro phosphorylation of tropomyosin by a kinase from chicken embryo. J. Biol. Chem. 259, 5555–5560 - PubMed
    1. Wu S. C., Solaro R. J. (2007) Protein kinase Cζ. A novel regulator of both phosphorylation and de-phosphorylation of cardiac sarcomeric proteins. J. Biol. Chem. 282, 30691–30698 - PMC - PubMed
    1. Yuan C., Solaro R. J. (2008) Myofilament proteins: from cardiac disorders to proteomic changes. Proteomics Clin. Appl. 2, 788–799 - PubMed

Publication types

MeSH terms

LinkOut - more resources